drugset / Trial / NCT00344253

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

NCT00344253

Phase 3 Completed 19 enrolled Heidelberg University Serono GmbH · collab
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to investigate if interferon beta is superior to the standard treatment with Methotrexate for the treatment of intermediate uveitis and macular edema.

Timeline

Start
2006-03
Primary completion
2011-03
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Interferon-beta Protein / enzyme biologic
Comparator Methotrexate Small molecule 20 mg Subcutaneous